| 产品描述: | MD2-TLR4-IN-1 (Compound 22m) 是一种 myeloid differentiation protein 2/toll-like receptor 4 (MD2-TLR4) 的有效抑制剂。MD2-TLR4-IN-1 (compound 22m) 可抑制脂多糖(LPS)诱导的 tumor necrosis factor alpha (TNF-α) 和 interleukin-6 (IL-6) 的表达,在巨噬细胞中对应的IC50值分别为0.89 μM和0.53 μM |
| 靶点: |
TLR4; IL-6(Cell-free assay):0.53 μM; TNF-α(Cell-free assay):0.89 μM;TLR |
| 体内研究: |
MD2-TLR4-IN-1 (5-10 mg/kg;尾静脉注射;一次;在注射 LPS 前 15 分钟) 显著抑制巨噬细胞浸润,并改善 LPS 攻击小鼠肺组织的组织病理学变化。 |
| 参考文献: |
1. Zhiguo Liu, et al. Discovery of 3-(Indol-5-yl)-indazole Derivatives as Novel Myeloid Differentiation Protein 2/Toll-like Receptor 4 Antagonists for Treatment of Acute Lung Injury. J Med Chem. 2019 Jun 13;62(11):5453-5469. |
| 溶解性: |
Soluble in DMSO、Ethanol |
| 保存条件: |
-20°C |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
2.374 ml |
11.869 ml |
23.737 ml |
| 5 mM |
0.475 ml |
2.374 ml |
4.747 ml |
| 10 mM |
0.237 ml |
1.187 ml |
2.374 ml |
| 50 mM |
0.047 ml |
0.237 ml |
0.475 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |